SCHEMBL29930702

SCHEMBL29930702

COc1cccc(-c2n[nH]c3ncc(Nc4cccc(OCc5ccccc5)c4)cc23)c1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 6/20 0.73
DYRK1A Q13627 5/20 0.65
MAOB P27338 1/20 0.49
STK10 O94804 1/20 0.45
SLK Q9H2G2 1/20 0.45
PTK6 Q13882 1/20 0.44
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
ABCB1 P08183 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
TTK P33981 1/20 0.43
BCHE P06276 1/20 0.43
CDK1 P06493 1/20 0.42
KDR P35968 1/20 0.42
ROCK2 O75116 1/20 0.42
GRK2 P25098 1/20 0.42
BTK Q06187 1/20 0.42
CTSV O60911 1/20 0.42
CTSL P07711 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930851 0.92 DYRK1B (0.73) DYRK1BDYRK1AMAOBSTK10SLK
SCHEMBL29930889 0.90 DYRK1B (0.69) DYRK1BDYRK1ATP53MAPTABCB1
SCHEMBL29930763 0.85 DYRK1B (0.71) DYRK1BDYRK1ASTK10SLKTP53
SCHEMBL29930701 0.78 DYRK1B (0.67) DYRK1BDYRK1AMAPT
SCHEMBL29930670 0.76 DYRK1B (0.70) DYRK1BDYRK1ASTK10SLKABCG2
SCHEMBL5533779 0.73 DYRK1B (0.43) DYRK1BDYRK1AMAPTTTKBCHE
SCHEMBL29930535 0.73 GAA (0.49) DYRK1BDYRK1AMAPT
SCHEMBL29930966 0.73 KIT (0.50) DYRK1BDYRK1ATTKBTK
SCHEMBL28675336 0.72 MAP4K1 (0.65) MAPT
SCHEMBL6098127 0.72 CTSV (0.65) MAOBSTK10SLKPTK6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed